Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Expert Rev Hematol. 2018 Feb 12;11(3):185–194. doi: 10.1080/17474086.2018.1435268

Figure 1:

Figure 1:

BTK is engaged downstream of the constitutively activated B cell receptor (BCR) in CLL. This leads to activation of phosphatidylinositol-3-kinase delta (PI3K?) and PLC?2 with subsequent hydrolysis of phosphatidylinositol-3-phosphate (PIP3) into diacylglycerol (DAG) and inositol-3-phosphate (IP3). Events downstream of activated BTK and PLC?2 include, but are not limited to, intracellular Ca2+ release as well as NF-?B and NFAT pathway activation.